Church & Dwight Cuts Outlook Due To Rising Costs, Adds Suppliers To Strengthen ‘Weak Links’
Executive Summary
“We expect higher input costs and transportation costs to remain elevated for the rest of the year,” says CEO Matthew Farrell. Firms lowers full-year outlook for net sales growth from previous range of 5% to 6% to around 5%.
You may also be interested in...
Church & Dwight Improves On Meeting Demand, But Doesn’t Deliver Better Full-Year Forecast
Lowers full-year forecast for reported sales growth to 4% to 5% from an earlier estimate of 5% to 8% despite improving to 89% on meeting demand during the April-June period from 80% during Q1.
Church & Dwight Meets Supply, Inflation Headwinds With Line Extensions, Price Increases
C&D executives didn’t downplay potential challenges during 2022 – including an expected $155m increase in costs from inflation – as they discussed the health, personal and household care manufacturer and marketer’s 2021 full-year and fourth-quarter results and its long-range plans.
Church & Dwight Chews On Strong Growth For Vitafusion As Consumers Stick To Category
Vitafusion gummy vitamins had 24% consumption growth in Q3 and Zicam homeopathic cold remedies had 40%. Church & Dwight plans to increase prices on 80% of portfolio by the end of the 2022 Q1.